CAR-T cell therapy approved for clinical study from MFDS for the first in Korea - 큐로셀

ABOUT US
R&D
- Technology
- Pipeline
- GMP
NEWS
COLLABORATION
- Business development
JOB
CONTACT

OVIS™ CD19 CAR-T cell therapy targeting DLBCL
(Code named: CRC01)

Jong Ran Kim

Head of Clinical Development Center

Executive Vice President

Jongran Kim

Head of Clinical Development Center
ABL Bio Executive Vice President, Clinical Devopment Team
Samsung Bioepis Vice President, Clinical Devopment Team
ICON APAC Vice President, Clin Ops – APAC
Eli Lilly, Regional Manager – Asia
Master of Science, Genetic Engineering, Korea University

Hyeun Jin Seo

Director

Regulatory Affairs

Hyeonjin Seo

Clinical Project Management
ChongKunDang Product/Bio development Senior Manager
Hanhwa Solution Regulatory Affairs Senior Manager

Mi Kyung Kim, Ph.D.

Director

External R&D

김미경

Director
Molecular Biology Mechanism Study
Professor of Biology at Yonsei Univ.
Post Doc., NYC Medical Center / Ph.D. of Biology, Yonsei Univ.

Hyerim Kang

Director

Managing Director of Clinical Project Management

강혜림 상무_2

Director
Clinical Project Manager
Samsung Bioepis Lucentis/Eylea Biosimilar Global Clinical Program Director
UCB Clinical Project Management Director
IQVIA Asia Reginal start-up Lead
Roche Clinical Vendor Manager

Changwan Hong, Ph.D.

Associate professor, Department of Anatomy, PNU School of Medicine

Outside director

thum

Ph.D., Cellular Immunology, Korea University
Chairman, Department of Convergence Medical Science, PNU School of Medicine

Suhee Cho

Director

Clinical development Advisor

조수희 이사

Clinical development advisor
Gyeongsang National Univ. department of Hemato-oncology
Pusan National University Yangsan Hospital Clinical assistant professor

Daniel Ryu

Law office Cheongdang Partner Attorney

Auditor

thum

Boston Univ. Law School

Jin Kyong Park

Chief Financial Officer

CFO / Director

PJK

LG Chemical R&D Strategic Planning
Chungnam national Univ. department of Business Administration

Hyun-Bo Sim, Ph.D.

Ewha Womans University Associate Professor of department of Bioinspired Science

심현보 교수 - 크기

Professor of EHWA Womans Univ.
XOMA Corp., a therapeutic antibody development / Researcher
SCRIPPS Laboratory, Humanized Antibody Discovery / Post Doc
Master of Chemistry, Seoul National Univ. / Dr. Texas A&M University, USA

Gunsoo Kim

CEO

DSC_6024 - 복사본

Chief Executive Officer
LG Chem. R&D, strategic planning 20 years
CHABiotech research planning
M.A. of Biotechnology, Yonsei University

Hyeong Cheol Kim, Ph.D

Executive Director

Head of R&D Center

KHC

Head of Technical Research Institute(R&D Center)
15 years of R&D experience, responsible for LG Chemistry’s biosimilar development
Ph. D., Univ. of Texas at Austin / Department of Microbiology, Seoul National Univ.

Chanhyuk Kim, Ph.D.

KAIST Assistant Professor of Department of Life Sciences

김찬혁 교수

Professor of KAIST
California Institute for Biomedical Research, Synthetic immunodynamics / PI
Post Doc., The Scripps Research Institute / Ph. D. of Chemistry, Seoul National Univ.

Jung Hee Lim

Intervest Executive Director

thum

We pursue a corporate culture that values and nurtures human resources. We aim for a company that pushes and attracts, and values communication and feedback.
Although it is a very difficult time because of COVID-19, Qurocell will do its best to showcase technologies that can contribute to the country and even the world.

Director

Head of production Engneering Center

Director

JDH

Head of GMP Center / Medical GMP specialist
LG Chem production and QA manager